Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2

• Main Authors: Mohamed Raafat (Author), Amr A. Kamel (Author), Alaa H. Shehata (Author), Al-Shaimaa F. Ahmed (Author), Asmaa M. A. Bayoumi (Author), Rabab A. Moussa (Author), Mohammed A. S. Abourehab (Author), Mahmoud El-Daly (Author)
• Format: Book
• Published: MDPI AG, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Benign prostatic hyperplasia (BPH) is the most common urogenital condition in aging males, while inflammation and tissue proliferation constitute the main pathophysiological factors. The adverse effects of currently available BPH medications limit patient compliance. We tested the protec...